Age-related cognitive decline occurs without frank neurodegeneration and is the most common cause of memory impairment in aging individuals. With increasing longevity, cognitive deficits, especially in hippocampus-dependent memory processes, are increasing in prevalence. Nevertheless, the neurobiological basis of age-related cognitive decline remains unknown. While concerted efforts have led to the identification of neurobiological changes with aging, few age-related alterations have been definitively correlated to behavioral measures of cognitive decline. In this work, adult (12 months) and aged (28 months) rats were categorized by Morris water maze performance as Adult cognitively Intact, Aged cognitively Intact or Aged cognitively Impaired, and protein expression was examined in hippocampal synaptosome preparations. Previously described differences in synaptic expression of neurotransmission-associated proteins (Dnm1, Hpca, Stx1, Syn1, Syn2, Syp, SNAP25, VAMP2 and 14-3-3 eta, gamma, and zeta) were confirmed between Adult and Aged rats, with no further dysregulation associated with cognitive impairment. Proteins related to synaptic structural stability (MAP2, drebrin, Nogo-A) and activity-dependent signaling (PSD-95, 14-3-3θ, CaMKIIα) were up-and down-regulated, respectively, with cognitive impairment but were not altered with increasing age. Localization of MAP2, PSD-95, and CaMKIIα demonstrated protein expression alterations throughout the hippocampus. The altered expression of activity-and structural stability-associated proteins suggests that impaired synaptic plasticity is a distinct phenomenon that occurs with age-related cognitive decline, and demonstrates that cognitive decline is not simply an exacerbation of the aging phenotype.
Introduction
Age-related cognitive decline impacts a variety of brain functions, and reduces quality of life for aging individuals by diminishing healthspan and increasing dependence. Currently, an estimated 40% of the otherwise healthy population over age 60 is affected by cognitive decline (Small, 2002) . Common age-related conditions such as hypertension and heart disease are risk factors for cognitive decline, and are associated with increased severity of cognitive deficits with advancing age (Qiu et al., 2005; Dahle et al., 2009; Okonkwo et al., 2010) . Due to lifespan increases, demographic shifts, and health care advances, the percentage of the population over age 60 is expected to increase to 20% by 2050 (Shrestha, 2006) . This prevalence of aged individuals is unique in human history, and the incidence of age-related health conditions is expected to rise concomitantly with our increasing lifespan. As such, concerted efforts are needed to understand, prevent, and treat age-related cognitive decline.
Previous characterizations of the hippocampal proteome and transcriptome with aging and cognitive decline (Poon et al., 2006; Blalock et al., 2003 Blalock et al., , 2005 Rowe et al., 2007Butterfield et al., 2006 Freeman et al., 2009b) have identified alterations in neurobiologically-relevant processes associated with advancing age, including increased oxidative stress, decreased glucose utilization and bioenergetic metabolism, and aberrant protein synthesis and trafficking. Although these processes are important to healthy neuronal function, a more immediate cause of cognitive decline is likely dysregulation of neurotransmission and synaptic plasticity. Electrophysiological correlates of hippocampal function are disrupted with aging and learning impairments, and are consistent with unstable encoding of spatial representations (Barnes et al., 1997; Kumar et al., 2007; Norris et al., 1996; Rosenzweig and Barnes, 2003; Wilson et al., 2003) . This instability manifests in resistance to LTP induction, facilitation of LTD, and aberrant spatiotemporal activation of ensemble networks. These characteristics may be related to atypical synapse morphology, neurotransmitter synthesis and receptor signaling, and neuronal gene and protein expression (Liu et al., 2008; Shi et al., 2005; Burke Neurobiology of Disease 43 (2011) 201-212 
